Amarin Corp Plc (AMRN)

[JRoon71]

It's not. This is the 2nd time HLS has materially reduced it's forward guidance of Vascepa sales.

And they indicated that part of the issue is lower than expected uptake by GP's (Pfizer's responsibility)

They have $8.0M YTD in Vascepa sales. Roughly 50% of that is through GP's. So Pfizer has generated roughly $4.0M in revenue for HLS for sales of Vascepa. Not exactly killing it.

And HLS is still losing money on Vascepa.